Vizsgálati helyszín
Urology Centers of Alabama
Homewood, Alabama 35209, Egyesült ÁllamokMég nincs intézményhez kötve
- 13futó vizsgálat
- 1lezárt vizsgálat
Az itteni vizsgálatok
Miről szól a helyszín 14 vizsgálata, a regiszteri adatlapjaik szerint.
- Fázis
- 3. fázis6 vizsgálat
- 2. fázis2 vizsgálat
- 1. fázis1 vizsgálat
- Állapot
- Fut, nem toboroz8 vizsgálat
- Toboroz5 vizsgálat
- Lezárult1 vizsgálat
- Fő szponzor
- Janssen Research & Development, LLC3 vizsgálat
- Bayer1 vizsgálat
- Curium US LLC1 vizsgálat
- Lantheus Medical Imaging1 vizsgálat
- MultiValent Biotherapies, Inc.1 vizsgálat
- és még 7
Futó vizsgálatok
Toboroz
A Phase 1 Study of MVB-101 Administered Intraprostatically in Patients With Localized Prostate Cancer Who Are Scheduled for Radical Prostatectomy
NCT07944508· 1. fázis· MultiValent Biotherapies, Inc.· Forrás
Contact: Meredith Sharpton, PA-C
Toboroz
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
NCT06774131· 3. fázis· UroGen Pharma Ltd.· Forrás
Contact: Rita Aderholt
Toboroz
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
NCT06995677· 2. fázis· Tyra Biosciences, Inc· Forrás
Contact: Gina Risdall
Toboroz
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
NCT06394869· Pacific Edge Limited· Forrás
Contact: Meredith A Sharpton, PA-C
Fut, nem toboroz
A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).
NCT06551324· 3. fázis· Pfizer· Forrás
Fut, nem toboroz
Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer
NCT06235151· 3. fázis· Curium US LLC· Forrás
Toboroz
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
NCT05951179· 2. fázis· Protara Therapeutics· Forrás
Contact: Chief Scientific Operations Officer
Fut, nem toboroz
A Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPC
NCT05884398· 3. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
An Observational Registry Assessing the Impact of PYLARIFY® (Piflufolastat F18) PET in Patients With Prostate Cancer
NCT05712473· Lantheus Medical Imaging· Forrás
Fut, nem toboroz
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-MutatedProstatic Neoplasms (mCSPC)
NCT04497844· 3. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing
NCT04404894· Myriad Genetic Laboratories, Inc.· Forrás
Fut, nem toboroz
A Study in Which Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) Patients for Whom a Decision to Treat With Darolutamide Has Been Made Before Enrollment Are Observed and Certain Outcomes Are Described
NCT04122976· Bayer· Forrás
Fut, nem toboroz
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer
NCT03748641· 3. fázis· Janssen Research & Development, LLC· Forrás
Egyszerre toboroz
Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.
Hibát jelzek